The Subject Expert Committee (SEC) of the Indian drug regulator will meet today to consider granting emergency approval to Russia’s Covid-19 vaccine Sputnik V, news agency ANI reports. Drugmaker Dr Reddy’s had last week submitted the safety and immunogenicity data the SEC had asked in the first meeting held on 24 February.
“Meeting of Subject Expert Committee to be held today to deliberate on emergency use authorisation application of Russian vaccine Sputnik V. The vaccine manufacturers in India, Dr Reddy’s, have already submitted the safety and immunogenicity data of the third phase trials
